Anticonvulsants, Newer



Anticonvulsants, Newer





Developed for the treatment of partial and generalized seizure disorders, these second-generation anticonvulsants are finding wider use in the treatment of chronic and neuropathic pain syndromes; mood disorders, including bipolar disease; and migraine headache prophylaxis. Serious adverse effects with the therapeutic use of felbamate (aplastic anemia, hepatic failure) and vigabatrin (permanent visual field deficits) have led to restrictions in their use.






Characteristics of several of these drugs are listed in Table II–6.







Table II-6 Anticonvulsant Drugs (Newer)